Tsimafeyeu, I., Guliyev, F., Musayeva, G., Abdrakhmanov, R., Chubenko, V., Baklanova, O., Zukov, R., Petkau, V., Myslevtsev, I., Kahharov, A., Ongarbayev, B., Kaidarova, D. (2025). Site-specific disease progression in patients with metastatic renal cell carcinoma treated with first-line nivolumab plus ipilimumab or axitinib-based immunotargeted combinations.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.5_suppl.478